Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Keaney

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Cardiovascular Research|August 30, 2000
Antioxidants and cardiovascular disease; panaceas or tonics for tired sheep?F Visioli, J F Keaney, B Halliwell
American Journal of Obstetrics and Gynecology|May 12, 2001
Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cellsW Kuohung, G T Shwaery, J F Keaney
Hypertension (Dallas, Tex. : 1979)|August 19, 2000
Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathioneA Xu, J A Vita, J F Keaney
Circulation|March 9, 1999
Vitamin C and endothelial dysfunction: what is new?A Ceriello, J F Keaney, J A Vita
Cardiovascular Research|August 30, 2000
Antioxidants and the bioactivity of endothelium-derived nitric oxideD Tomasian, J F Keaney, J A Vita
Free Radical Biology & Medicine|November 7, 2000
Glucose enhancement of LDL oxidation is strictly metal ion dependentH O Mowri, B Frei, J F Keaney
Antioxidants & Redox Signaling|February 24, 2001
Redox control of vascular nitric oxide bioavailabilityD T Price, J A Vita, J F Keaney
Atherosclerosis|August 5, 1998
Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiolG T Shwaery, J A Vita, J F Keaney
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 1999
Vitamin E and vascular homeostasis: implications for atherosclerosisJ F Keaney, D I Simon, J E Freedman
The New England Journal of Medicine|February 23, 1995
Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanismsG N Levine, J F Keaney, J A Vita
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Cardiovascular Research|August 30, 2000
Antioxidants and cardiovascular disease; panaceas or tonics for tired sheep?F Visioli, J F Keaney, B Halliwell
American Journal of Obstetrics and Gynecology|May 12, 2001
Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cellsW Kuohung, G T Shwaery, J F Keaney
Hypertension (Dallas, Tex. : 1979)|August 19, 2000
Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathioneA Xu, J A Vita, J F Keaney
Circulation|March 9, 1999
Vitamin C and endothelial dysfunction: what is new?A Ceriello, J F Keaney, J A Vita
Cardiovascular Research|August 30, 2000
Antioxidants and the bioactivity of endothelium-derived nitric oxideD Tomasian, J F Keaney, J A Vita
Free Radical Biology & Medicine|November 7, 2000
Glucose enhancement of LDL oxidation is strictly metal ion dependentH O Mowri, B Frei, J F Keaney
Antioxidants & Redox Signaling|February 24, 2001
Redox control of vascular nitric oxide bioavailabilityD T Price, J A Vita, J F Keaney
Atherosclerosis|August 5, 1998
Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiolG T Shwaery, J A Vita, J F Keaney
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 1999
Vitamin E and vascular homeostasis: implications for atherosclerosisJ F Keaney, D I Simon, J E Freedman
The New England Journal of Medicine|February 23, 1995
Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanismsG N Levine, J F Keaney, J A Vita
Pageof 8